skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes

Original Research

(1995) Views  (716) Full article downloads

Authors: Darja Kanduc

Published Date September 2010 Volume 2010:4 Pages 245 - 261
DOI: http://dx.doi.org/10.2147/BTT.S12097

Darja Kanduc
Department of Biochemistry and Molecular Biology, University of Bari, Italy

Abstract: We searched the primary sequence of influenza A H5N1 polyprotein for hexamer amino acid sequences shared with human proteins using the Protein International Resource database and the exact peptide matching analysis program. We find that the viral polyprotein shares numerous hexapeptides with the human proteome. The human proteins involved in the viral overlap are represented by antigens associated with basic cell functions such as proliferation, development, and differentiation. Of special importance, many human proteins that share peptide sequences with influenza A polyprotein are antigens such as reelin, neurexin I-a, myosin-IXa, Bardet–Biedl syndrome 10 protein, Williams syndrome transcription factor, disrupted in schizophrenia 1 protein, amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein, fragile X mental retardation 2 protein, and jouberin. That is, the viral-vs-human overlap involves human proteins that, when altered, have been reported to be potentially associated with multiple neurological disorders that can include autism, epilepsy, obesity, dystonia, ataxia–telangiectasia, amyotrophic lateral sclerosis, sensorineural deafness, sudden infant death syndrome, Charcot-Marie-Tooth disease, and myelination. The present data are discussed as a possible molecular basis for understanding influenza A viral escape from immunosurveillance and for defining anti-influenza immune-therapeutic approaches devoid of collateral adverse events.

Keywords: peptide sharing, neurological disorders, host-pathogen relationships, viral escape from immunosurveillance




 

Other articles by Professor Darja Kanduc



Readers of this article also read:

Therapeutic vaccines for malignant brain tumors
Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women: a review
Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib
Safety and immunogenicity of Salmonella typhimurium expressing C-terminal truncated human IL-2 in a murine model
Hepatitis B virus and Homo sapiens proteomewide analysis: A profusion of viral peptide overlaps in neuron-specific human proteins
Potential role of ustekinumab in the treatment of chronic plaque psoriasis
Palliative treatment of malignant ascites: profile of catumaxomab
Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS)
Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma
New and emerging treatment approaches to lupus
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University

  • Journal Indexing

    See where all the Dove Press journals are indexed